G1 THERAPEUTICS, INC.

Company Information

Company Name
G1 THERAPEUTICS, INC.
Address
79 TW Alexander Dr
RESEARCH TRIANGLE PARK, NC, 27709-0152
Phone
n/a
URL
n/a
DUNS
828732813
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,003,277.00
3
SBIR Phase II
$3,984,830.00
2
Chart code to be here

Award List

  1. Organismal Radioprotection Through Pharmacological Quiescence

    Amount: $692,326.00

    DESCRIPTION (provided by applicant): Hematologic toxicity is a principal cause of morbidity and mortality after exposure to ionizing radiation (IR). G-Zero Therapeutics, with operations in the Res ...

    SBIR Phase I 2009 Department of Health and Human Services
  2. Organismal Radioprotection Through Pharmacological Quiescence

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): Syndrome (ARS), including a lethal myelosuppression due to the sensitivity of proliferating hematopoietic stem/progenitor cells (HSPCs) to ionizing radiation (IR). ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Development of CDK4/6 Inhibitors as Novel Renal Protectants

    Amount: $159,836.00

    DESCRIPTION (provided by applicant): Acute kidney injury (AKI) is common, expensive, and highly morbid. There are currently no therapies for AKI, and prevention and treatment represents a 6.3 billion ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. A new multiphase polymeric material for cushion-bearing orthopedic implants

    Amount: $151,115.00

    DESCRIPTION (provided by applicant): Myelosuppression continues to represent the major dose-limiting toxicity of cancer chemotherapy, resulting in considerable morbidity and mortality along with frequ ...

    SBIR Phase I 2013 Department of Health and Human Services
  5. Development of GZ38-1, a Novel Protectant of Chemotherapy-Induced Myelosuppressio

    Amount: $984,830.00

    DESCRIPTION (provided by applicant): Myelosuppression continues to represent the major dose-limiting toxicity of cancer chemotherapy, resulting in considerable morbidity and mortality along with frequ ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government